Robert S. Negrin

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

Matthias Edinger, Petra Hoffmann, Joerg Ermann et al. · Nature Medicine · 2003 · 1.3K citations

Cell Therapy, Graft-versus-host Disease, Transplantation +13

Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation

Loredana Ruggeri, Marusca Capanni, Myriam Casucci et al. · Blood · 1999 · 987 citations

Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic Cancers

William Bensinger, Paul J. Martin, Barry E. Storer et al. · New England Journal of Medicine · 2001 · 961 citations · Full text

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 537 citations · Full text

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke et al. · Leukemia · 2015 · 535 citations · Full text

Transplantation, Stem Cell Transplantation, Transplantation Medicine +9